Jaxrane Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
as on 12-12-2024
- Revenue -12.90%
(FY 2023)
- Profit 34.05%
(FY 2023)
- Ebitda 117.76%
(FY 2023)
- Net Worth 36.51%
(FY 2023)
- Total Assets 19.40%
(FY 2023)
About Jaxrane Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 M.
Narender Singh and Rajni serve as directors at the Company.
- CIN/LLPIN
U24299HR2021PTC092839
- Company No.
092839
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jaxrane Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narender Singh  | Director | 10-Feb-2021 | Current |
| Rajni | Director | 28-Jan-2024 | Current |
Financial Performance of Jaxrane Remedies.
Jaxrane Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.9% decrease. The company also saw a substantial improvement in profitability, with a 34.05% increase in profit. The company's net worth Soared by an impressive increase of 36.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaxrane Remedies?
In 2023, Jaxrane Remedies had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jun 2024 | ₹3.50 M | Open |
How Many Employees Work at Jaxrane Remedies?
Jaxrane Remedies has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaxrane Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaxrane Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
